Percutaneous endovascular treatment for stenoses and occlusions of infrarenal aorta and aortoiliac bifurcation: Midterm results  by d'Othée, B.J. et al.
Percutaneous Endovascular Treatment for Stenoses and Occlusions
of Infrarenal Aorta and Aortoiliac Bifurcation: Midterm Results
B. J. d'OtheÂe1, S. Haulon2, C. Mounier-Vehier3, J. P. Beregi1, O. Jabourek3 and S. Willoteaux1
Departments of 1Vascular Radiology, 2Vascular Surgery and 3Hypertension and Vascular Disease, HoÃpital
Cardiologique, Centre Hospitalier ReÂgional Universitaire (C.H.R.U.) de Lille, Lille, France
Objective: evaluation and comparison of the endovascular treatment of isolated aortic and aortoiliac atherosclerotic lesions
(stenoses and occlusions).
Methods: a percutaneous endovascular procedure was performed in 52 patients (38 men and 14 women) with a mean age of
52 years (range, 25±85 years). The baseline angiogram showed 35 aortic lesions (31 stenoses, 4 occlusions) and 17 aortoiliac
lesions (14 stenoses, 3 occlusions). Percutaneous techniques used in this series included variable combinations of
transluminal angioplasty and stenting. All stents placements were performed over-the-wire using the transfemoral route
(most often bilateral approach). Clinical examination and Duplex-scan were performed at discharge, 1 month, 6 months,
12 months, and then yearly.
Results: technical success was 100% for aortic and aortoiliac lesions. Angiographic success rates were comparable for
aortic (91%) and aortoiliac (94%) lesions. No death occurred during or early after the endovascular intervention. Duplex-
scan confirmed 100% patency rate at discharge. There was no significant difference between the aortic (94%) and aortoiliac
(96%) groups regarding immediate clinical improvement. Mean follow-up was 34+ 31 months (range, 0±130 months).
The cumulative primary patency rate at 36 months was 85% in the aortic group and 86% in the aortoiliac group. Clinical
success, defined as a symptom-free status at the end of follow-up, was also similar in both groups.
Conclusion: endovascular treatment of isolated aortic lesions of the infra-renal aorta has favorable outcomes comparable to
those of aortoiliac lesions.
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Introduction
As opposed to the coronary, iliac, and femoral arteries,
a more limited literature has focused on percutaneous
treatment for stenoses of the infrarenal aorta.1±7 After
the first isolated case reports8±11 in the early 1980s,
some of the first cohort studies12±16 (1989±93) mixed
lesions involving the infrarenal aorta with those
located at the aortoiliac bifurcation. Later and
larger retrospective cohort reports1,2,4,17±19 (1994±98)
excluded appropriately pure iliac lesions. However,
all but two1,2 of these studies were based on groups
that did not exceed 25 patients and had limited follow-
up.17±41 Two articles, published in 19962 and 19981
respectively, have reported larger series of patients
having undergone endovascular treatment for aortic
stenoses (n 38 and 102 respectively). In these reports,
the endovascular option proved to be safe, efficacious,
and less invasive then open surgery,3,18,20,22 with no
need for abdominal incision and general anaesthesia,
lower morbidity and mortality, shorter procedure time
and hospital stay, and lower cost. Preservation or
improvement of sexual function in males was also
reported with both PTA2 and stent placement.15 More
recent investigations have suggested that stent place-
ment in the abdominal aorta was a valuable therapeutic
strategy in case of unsuccessful or suboptimal balloon
angioplasty.5,15,16,26
To date, the literature on endovascular therapy of
the infrarenal aorta has included mostly stenotic
lesions, the treatment of aortic occlusions being
reported in 29 patients only.15,16,23,30,33,41 To our know-
ledge, there has not been any report comparing spe-
cifically the results of endovascular treatment in aortic
versus aortoiliac lesions, and many series have mixed
both, sometimes without making any difference
between them. The purpose of the present study was
to compare the short and midterm outcome of both
groups with updated criteria for classifying risk
factors.42±44 and the type of aortic lesion.45
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Methods
Population
Over a 130 month period, a percutaneous endovascu-
lar procedure was performed for the treatment of aor-
tic or aortoiliac obstructive disease in 52 consecutive
patients (38 men and 14 women) with a mean age of
52 years (range, 25±85 years). The cardiovascular risk
factors (SVS/ISCVS grade 2),42±44 and the clinical
status of the patients (SVS/ISCVS classification)
before the endovascular procedure, are reported in
Table 1. The indications for treatment included mod-
erate or severe claudication according to the SVS/
ISCVS classification in most cases, but also a blue toe
syndrome in two patients and a Leriche syndrome in
two other patients. Patients with critical ischemia
were treated by conventional surgery.
Inclusion criteria
When reviewing our imaging files, a first division was
made between isolated lesions of the infrarenal aorta
only (i.e., more than 2 cm above the aortic bifurcation)
versus lesions involving the distal 2 cm of the aorta
and/or the proximal portions of the common iliac
arteries.1 Patients with obstructive lesions involving
the iliac arteries only (i.e., without associated signifi-
cant aortic stenosis or occlusion) were excluded. The
purpose of this subdivision in aortic and aortoiliac
groups was to differentiate midaortic lesions from
lesions involving the aortic bifurcation. The rationale
for that was that the pathogenesis of midaortic lesions
may be varied and remains unclear today, whereas
lesions of the aortic carrefour are almost always
related to atheroma.
A second division was applied to the aortic group
only (Table 2), on the basis of the classification of the
American Heart Association Task Force on Peripheral
Percutaneous Transluminal Angioplasty.44
Pre-interventional angiographic findings
The baseline angiogram showed 35 aortic lesions
(31 stenoses, 4 occlusions) and 17 aortoiliac lesions
(14 stenoses, 3 occlusions).
The 35 aortic lesions consisted of class I lesions in 14
patients, class II lesions in 11 patients, class III lesions
in 6 patients, and class IV lesions in 4 patients (Fig. 1a).
The median length of these aortic lesions was 2 cm
(range, 0.5±7 cm) and was poorly correlated to the
initial claudication distance (ICD) for either the
whole cohort, the aortic group, or the aortoiliac group.
Table 1. Cardiovascular risk factors (SVS/ISCVS grade 2), and
clinical status (SVS/ISCVS classification), of the 52 patients be-
fore the endovascular procedure.
Aortic group
(n 35)
Aortoiliac group
(n 17)
Mean age (range) 53 (35±85) 51 (25±66)
Sex (M/F) 23 (66%)/12 15 (88%)/2
Tobacco use 21 (60%) 12 (71%)
Diabetes 5 (14%) 4 (24%)
Hypertension 16 (46%) 5 (29%)
Hyperlipidemia 15 (43%) 8 (47%)
Cardiac status 10 (29%) 2 (12%)
Carotid disease 5 (14%) 2 (12%)
Renal status 3 (9%) 0
Respiratory status 1 (3%) 0
Moderate claudication 15 (43%) 8 (47%)
Severe claudication 20 (57%) 9 (53%)
Tobacco use: current (includes abstinence less than 1 year), less than
1 pack/day; or current, greater than 1 pack/day.
Diabetes: adult onset, insulin-controlled; or juvenile onset.
Hypertension: controlled with two drugs, or requires more than
two drugs or is uncontrolled.
Hyperlipidemia: moderate elevation requiring strict dietary con-
trol, or severe enough to require dietary and drug control.
Cardiac status: stable angina, no angina but significant reversible
perfusion defect on dipyridamole thallium scan, significant silent
ischemia (1% of time) on Holter monitoring, ejection fraction
25%±45%, controlled ectopy or asymptomatic arrhythmia, history
of congestive heart failure that is now well compensated; or any one
of the following: unstable angina, symptomatic or poorly controlled
ectopy/arrhythmia (chronic/recurrent), poorly compensated or
recurrent congestive heart failure, ejection fraction5 25%, myocar-
dial infarction within 6 months.
Carotid disease: transient or temporary stroke or completed
stroke with permanent neurologic deficit or acute stroke.
Respiratory status: vital capacity 5 1.85 L, FEV151.2 L or 5 35%
of predicted, maximal voluntary ventilation 5 50% of predicted,
Pco24 45 mmHg, supplemental oxygen use medically necessary,
or pulmonary hypertension.
Table 2. Classification of isolated lesions of the infrarenal abdom-
inal aorta on the basis of the classification of the American Heart
Association Task Force on Peripheral Percutaneous Transluminal
Angioplasty.44
Category I
Short segment stenoses of the infrarenal abdominal aorta (less
than 2 cm long) with minimal atherosclerotic disease of the
aorta otherwise
Category II
Medium-length stenoses of the infrarenal abdominal aorta
(2±4 cm long) with mild atherosclerosis of the aorta otherwise
Category III
Long segment stenosis of the infrarenal abdominal aorta
(44 cm long), aortic stenosis with atheroembolic disease
(blue toe syndrome), or medium-length stenosis of the
infrarenal abdominal aorta (2±4 cm long) with moderate to
severe atherosclerosis of the aorta otherwise
Category IV
Aortic occlusions and aortic stenoses associated with an
abdominal aortic aneurysm
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Endovascular procedure
Procedures were performed in the angiosuite, or in the
operating room by a combined radiosurgical team.
Percutaneous techniques used in this series included
variable combinations of PTA and stenting. The sizing
of balloons and stents was based on measures pro-
vided by arteriography and, when available, CT angio-
graphy (Fig. 1b). Angioplasty was performed either by
inflation of a single large balloon above the aortic
bifurcation or by the kissing balloon technique,
depending on the anatomic distribution of the lesions.
Primary stent insertion was achieved in two patients
who presented with bilateral blue toe syndrome.
Secondary placement was performed in the other
stented cases, based on the presence of suboptimal
PTA results. Suboptimal PTA result was defined as
haemodynamic failure (i.e., residual systolic pressure
gradient above 20 mmHg and/or residual mean pres-
sure gradient above 10 mmHg without vasodilation
pharmacologic test) and/or angiographic failure (i.e.,
residual stenosis450%). All stents placements were
performed over-the-wire using the transfemoral route
(most often bilateral approach).
Anticoagulation and antithrombotic treatment
In all cases, acetylsalicylic acid (160 mg/day) was
started at least 10 days before the procedure and con-
tinued after the procedure. During the procedure, a
2500 IU intravenous or in situ (intraarterially) bolus of
heparin was administrated. If a kissing stent implanta-
tion was performed, acetylsalicylic acid (160 mg/day)
was combined with ticlopidine (250 mg/day) after the
procedure during 6 weeks.
Follow-up
Clinical examination and Duplex-scan were per-
formed at discharge, 1 month, 6 months, 12 months,
and then yearly. Data from the clinical and imaging
follow-up were updated by phone contact and/or by
appointment when necessary. A restenosis was con-
sidered significant on Duplex-scan when 450%.
Statistical analysis
Statistical analysis was performed to compare either
(1) the aortic group (35 patients) versus the aortoiliac
group (17 patients), or (2) aortic stenoses (31 patients)
versus aortoiliac stenoses (14 patients). Patients with
occlusive lesions were not used by themselves as inde-
pendent samples because of their small number (n 4
and 3, respectively).
After checking for normal distribution and homo-
geneity of variance of every variable, bivariate statis-
tical analysis was performed using non-parametric
Fig. 1. Preoperative angiography (a) and Helical CT (b) of an aortic
occlusion (category IV lesion). Angiographic result (c) after balloon
angioplasty and stent placement.
518 B. J. d'OtheÂe et al.
Eur J Vasc Endovasc Surg Vol 24, December 2002
tests (Student's t-tests). Survival curves were built
using the Kaplan±Meier method and differences
between the aortic and aortoiliac groups were studied
by using the log rank, Breslow, and Tarone±Ware tests.
A p value5 0.05 was considered significant in all
statistical analyses.
Results
Population
To test for homogeneity of RFs distribution between
aortic and aortoiliac groups, comparisons were con-
ducted on all the predictors listed in Table 1. There
was no statistically significant difference between
both groups in any of these factors. When comparing
aortic stenoses versus aortoiliac stenoses for the same
variables, the only statistically significant difference
was gender: there was a higher (p5 0.014) male pre-
dominance (14M/0F) in the later group as opposed to
a lower male-to-female ratio (21M/10F) in the former.
Comparisons between aortic and aortoiliac groups
(all lesions), as well as those between aortic and
aortoiliac stenoses, did not show any significant
difference in terms of initial presenting symptoms
(either SVS/ISCVS classification or initial claudication
distance [ICD]).
Endovascular procedure
Technical success at the end of the procedure (endo-
vascular treatment performed and mean pressure
gradient515 mmHg at the end of the procedure)
was achieved in all patients. Technical success was
therefore 100% for aortic and aortoiliac lesions. Angio-
graphic success at the end of the procedure (defined
as a residual stenosis530% in diameter) was
achieved in all patients with occlusions (Fig. 1c) (i.e.,
4 class IV aortic lesions and 3 aortoiliac occlusions).
Among aortic stenoses, one patient in each class had
a significant residual endoaortic bud, but the pressure
gradient had returned to normal values. In aortoiliac
stenoses, one patient also had an imperfect angio-
graphic result but no further treatment was deemed
necessary. Overall, there was no significant difference
in early angiographic success rates between the aortic
(91%) and aortoiliac (94%) groups nor between aortic
(90%) and aortoiliac (93%) stenoses.
Early and late complications after the endovascular
procedure are summarised in Table 3. No death
occurred during or early after the endovascular
intervention.
Duplex-scan confirmed 100% patency rate at dis-
charge. The immediate clinical outcome was defined
according the SVS/ISCVS criteria on a scale of ÿ1 to
3 for symptoms. There was no significant difference
between the aortic (94%) and aortoiliac (96%) groups
nor between aortic (95%) and aortoiliac (97%) stenoses
regarding immediate clinical improvement.
Follow-up
Mean follow-up was 34 31 months (range, 0±130
months). Complete follow-up clinical and duplex-
scan data were available in 47 patients (90%). The
five other patients were lost to follow-up. Follow-up
length was not significantly different between aortic
versus aortoiliac groups, nor between aortic and
aortoiliac stenoses.
Among class I aortic stenoses patients, one devel-
oped an aortic restenosis (450%) at 37 months of
follow-up and was successfully treated by stent place-
ment. In another patient, a focal aortic dissection asso-
ciated with a 2 cm-diameter pseudoaneurysm was
diagnosed at 25 months follow-up.
Class II and class III patients had no complications
or events during the follow-up. In one patient with
a class IV lesion, intrastent restenosis occurred 11
months after the initial procedure and was treated by
PTA with subsequent disappearance of the pressure
Table 3. Early and late complications according to the arterial lesion.
Lesion (n) Early complications (530 days) Late complications (430 days)
Aortic stenoses (31) Iliac occlusion during procedure Aortic restenosis
Iliac occlusion Aortic dissectionpseudoaneurysm
Aortic dissection
Aortic dissectionpseudoaneurysm
Aortic occlusions (4) ± Aortic restenosis
Aortoiliac stenoses (14) Convulsive crisis during procedure Aortoiliac occlusion
Iliac rupture
Aortoiliac occlusions (3) Retroperitoneal hematoma ±
Iliac occlusion
Iliac: Common iliac artery.
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gradient. One patient treated for aortoiliac stenoses
presented a late thrombosis of the aortoiliac carrefour
and was referred to surgery.
The early and late complication rates were similar
in the aortic and aortoiliac groups. Delayed mortality
was related to a bronchial carcinoma in one; patient
(death at 54 months), coronary artery disease in two
patients (death at 33 and 34 months) and an undeter-
mined cause in one patient (death later than 34 months).
All these four patients had experienced complete
relief of their symptoms during the first 2 years of
follow-up. The difference in mortality rates was not
statistically significant between the aortic and aorto-
iliac groups (two patients with aortic stenoses, two
patients with aortoiliac lesions). Similar conclusions
were drawn when comparing aortic and aortoiliac
stenoses.
In the aortic group, the cumulative primary patency
rate was 93% at 12 and 24 months, and 85% at
36 months. In the aortoiliac group, the cumulative
primary patency rate was 94% at 12 and 24 months,
and 86% at 36 months.
According to the results of the Kaplan±Meier sur-
vival analysis (Fig. 2), the cumulative primary patency
rates were similar in the aortic group and in the aorto-
iliac group. Clinical success, defined as a symptom-
free status at the end of follow-up, was also similar in
both groups. When including both symptom-free and
mild claudicant patients in the definition of clinical
success, both groups were also comparable.
Discussion
Obstructive disease of the infrarenal aorta may present
as an isolated aortic obstacle and/or an obstructive
involvement of the aortoiliac bifurcation. In the first
case, isolated stenoses of the distal aorta are believed
to involve a special subset of patients.21,36 They may
consist of a typical endoaortic bud (`` coral reef''),
either calcified or not, and this presentation seems
more frequent in young smoking women. Their exact
pathogenesis still remains partially unclear, even if
several authors consider it as a particular manifest-
ation of aortic atherosclerosis.21,36,46 In the second and
more common case, the involvement of the aortoiliac
carrefour by obstructive material is classically consid-
ered as a typical manifestation of atherosclerosis with
its preferential location at vessel bifurcations. As such,
its occurrence is influenced by the same risk factors as
other presentations of atherosclerosis, and therefore is
more frequent in elderly and male patients.
Plaque ulceration may also present as a blue toe
syndrome, which has been previously described as an
interesting indication for primary aortic stenting,1,6,14
as this technique reportedly reduces the risk of distal
embolization from such lesions. In the present study,
however, no difference was shown between lesions of
the infrarenal aorta alone and lesions of the aortoiliac
bifurcation. Also, the class of aortic lesion does not
seem to influence the outcome, either in terms of
technical success, patency, complication or mortality
rates. The relevance of these findings could warrant
further prospective studies, as they support the hypo-
thesis that the results of endovascular treatment could
be similar at both levels and thus this could lead one
to rethink the respective indications for endovascular
and open surgical treatment. Whereas the indications
of both options are now well codified at the level of
the aortic bifurcation, their relative role at the infra-
renal level (as well as the relative role of PTA versus
stenting) could warrant further prospective studies.
Despite the progressive emergence of appropriate
guidelines over more than a decade,42,44 cardiovascu-
lar risk factors (RFs) have not been used systematical-
ly in the literature on endovascular treatment of the
aorta to date. In the present series, all but one of the
RFs (gender) were similar in both groups. Although
most series have reported a female predominance, the
male predominance found in both groups of the pre-
sent series is a feature that had also been reported by
others.6,10,16,23
Probably the most controversial issue remaining to
date is the assessment of the early and late results of
the procedure. As agreed on by most authors,19 we
believe that an imperfect cosmetic result on DSA or
CT is not an indicator of immediate failure of the
intervention. One would intuitively expect that the
presence of a heavily calcified endoaortic bud could
preclude an appropriate opening of the stent or
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analysis) after endovascular treatment of the aortic and aortoiliac
lesions.
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impinge a fully unwaisted inflation of the balloon
during PTA. However, some cases in our series
showed remarkable adaptation over time of the aortic
wall contralateral to the bud so that a nearly normal
aortic caliber could be obtained. This is in accordance
with the presence of a `` remodelling'' phenomenon,
which has also been described after PTA of native
coarctations of the aortic isthmus.47 The lack of correla-
tion between imaging and symptoms was also present
in several of our patients treated either by PTA or stent
insertion. For example, three of our patients remained
completely asymptomatic despite residual reductions
in aortic diameter of 20, 30 and 40% respectively.
Like open surgery, the percutaneous approach is by
no means restricted to treating the aorta only. In the
aortic group, we treated associated renal arterial ste-
noses in four patients and iliac lesions in five patients
by PTA and/or stenting. In the aortoiliac group, five
patients were also treated for other concomitant iliac
lesions during the initial procedure.
The major complications of endovascular treatment
reported in the literature are of three main types: aor-
tic rupture, aortic dissection, and distal emboli.
Regarding the first one, many authors2,6,11,14,17±19,22,27
have invoked the Laplace's law to claim that the aorta
was at higher risk than smaller arteries (wall stress
[pressure radius]/[2wall thickness]). It is com-
monly assumed that the size of the PTA balloon
should be equal or inferior to the diameter of the
lumen of the healthy aortic portion immediately
upstream.6±7 In our series, 20 mm and even 25 mm-
wide balloons have been used in some patients; no
aortic rupture has occurred, and the two cases of
pseudoaneurysms discovered during the follow-up
had had balloons of only 14 and 16 mm in diameter,
respectively. There might be other factors involved in
the rupture mechanism. For instance, Laplace's law
does not explain by itself why, in general, PTA-related
ruptures occur more frequently in the external than
the common iliac arteries, thus pleading in favor of the
existence of other parameters such as vessel wall
structure. Calcifications had been suspected by early
investigators as a risk factor for aortic rupture.27 Since
then, however, PTA has been performed in calcified
aortic stenoses with good technical and clinical out-
come.6 In a literature review, we found 606 reported
patients treated percutaneously between 1980 and
2000; among them, only one case of aortic rupture
had been reported and it occurred in 1986.27 In that
case, manual pressure was applied to inflate the PTA
balloon, as opposed to the use of an inflation device.
On the other hand, multivariate analysis1 suggests
that the frequency of symptom recurrence decreases
as the dilatation diameter of the PTA balloon
increases. Our results and the opinion of others18
also support the idea that PTA and/or stenting of the
infrarenal aorta carries a very low risk of rupture.
Secondly, an aortic dissection may also occur as a
complication of the procedure. This has been scarcely
described during aortic PTA,19 although minor
residual dissections without significant hemodynamic
consequences are probably a common occurrence. We
have also observed such cases with small and non
obstructive dissections after PTA, sometimes persisting
and stable for more than 7 years. This `` complication''
has probably been underreported, as its clinical rele-
vance is probably minor except in the case of pseu-
doaneurysms developing during the follow-up. The
exact risk of developing pseudoaneurysmal complica-
tions is therefore difficult to determine from the
currently available data. Thirdly, there has been
some concern that procedures at the level of the infra-
renal aorta could be associated with distal emboliza-
tion and local complications at the femoral puncture
site, although this has in fact been reported in two
cases only.22 The risk of distal embolization also exists
during surgery.5 Distal embolization occurred in only
one of our patients in whom in situ thrombolysis was
performed as an adjuvant therapy and resulted in
clinical success with no major bleeding complication.
Usually, these emboli do not go farther than the bifur-
cation of the common femoral artery, as experienced
by us as well as by others.22
There are several potential limitations to our study.
First, this is a retrospective cohort study. Second,
patients' symptoms could not be reliably classified
according to the SVS±ISCVS system as the Leriche
and Fontaine classification remains the prevailing
one in everyday clinical practice at our institution, as
is the case in most parts of the world. Third, some data
were sometimes impossible to obtain in certain cases,
such as the ABIs and intraarterial pressure measure-
ments and gradients.1 Fourth, the decision process
used by each contributing investigator during the
treatment of these lesions was not standardised;
however, all methods of treatments were usual and
accepted at the time of treatment. Several primary
operators were involved in these percutaneous pro-
cedures, and technical evolution of the percutaneous
materials occurred during the nearly 11-year period
encompassed in this study. Thus, because this manu-
script encompassed a long time frame, its main aim
was to study the overall results of endovascular treat-
ment, not to report the comparative results of each
technical variant included in this series. In conclusion,
the outcome of endovascular treatment of infrarenal
aortic stenoses and thromboses should be assessed as
a multidimensional entity. The relative indications of
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each therapeutic modality available have yet to be
precised. Therefore, after more than two decades of
experience, time has hopefully come to answer that
essential question in a multicentre randomised con-
trolled trial comparing angioplasty, stenting, and open
surgery.
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